LASSBio-596

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameLASSBio-596
Drug Alias NameLASSBio-596
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitorsPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5APhosphodieterase 4
Therapy Area/IndicationsAcute Lung Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAcute Lung Injury

Other Information

ATC CodeN/A
Related LinksN/A